Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL59030 (GW3965) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133] | ||||||||
ChEMBL | Binding affinity to full-length human LXRalpha by surface plasmon resonance assay | B | 5.16 | pKd | 6970 | nM | Kd | J Med Chem (2021) 64: 9943-9959 [PMID:34251816] |
ChEMBL | Displacement of [N-methyl-3H]GW0438 from human biotinylated LXRalpha ligand binding domain | B | 6.63 | pIC50 | 235 | nM | IC50 | J Med Chem (2008) 51: 5758-5765 [PMID:18800767] |
ChEMBL | Displacement of [3H]T-0901317 from human LXR alpha receptor | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2006) 49: 6151-6154 [PMID:17034119] |
ChEMBL | Displacement of [3H]TO901317 from human recombinant LXRalpha expressed in Escherichia coli by flashplate method | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2008) 51: 7161-7168 [PMID:18973288] |
ChEMBL | Antagonist activity at LXRalpha ligand binding domain assessed as inhibition of T1317-induced transcriptional activity in african green monkey CV1 cells co-transfected with Gal4-SRC1 by luciferase reporter assay | B | 7 | pIC50 | 100 | nM | IC50 | J Med Chem (2010) 53: 3412-3416 [PMID:20345102] |
ChEMBL | Agonist activity at LXRalpha (unknown origin) | B | 5.89 | pEC50 | 1300 | nM | EC50 | Bioorg Med Chem Lett (2015) 25: 2668-2674 [PMID:25998501] |
ChEMBL | Agonist activity at Gal4-tagged LXRalpha (unknown origin) expressed in CHOK1 cells after 24 hrs by luciferase reporter gene assay | B | 5.89 | pEC50 | 1300 | nM | EC50 | Bioorg Med Chem Lett (2015) 25: 1274-1278 [PMID:25677664] |
ChEMBL | Agonist activity at human LXRalpha by Gal4 assay | B | 5.95 | pEC50 | 1128 | nM | EC50 | J Med Chem (2016) 59: 3264-3271 [PMID:26990539] |
ChEMBL | Agonist activity at LXRalpha ligand binding domain-mediated transcriptional activity in african green monkey CV1 cells co-transfected with Gal4-SRC1 by luciferase reporter assay | B | 6.1 | pEC50 | 794.33 | nM | EC50 | J Med Chem (2010) 53: 3412-3416 [PMID:20345102] |
ChEMBL | Agonist activity at human recombinant LXRalpha ligand binding domain in human HuH7 cells co-transfected with fused Gal4-DBD by transactivation assay | B | 6.18 | pEC50 | 660 | nM | EC50 | J Med Chem (2008) 51: 7161-7168 [PMID:18973288] |
ChEMBL | Agonist activity at LXRalpha LBD by HTRF cofactor peptide recruitment assay | F | 6.44 | pEC50 | 367 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 3473-3479 [PMID:17416521] |
ChEMBL | Agonist activity at human LXRalpha receptor after 1 hr by HTRF cofactor recruitment assay | F | 6.44 | pEC50 | 367 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4442-4446 [PMID:17587573] |
ChEMBL | Agonist activity at human LXRalpha expressed in human SH-SY5Y cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assay | F | 6.51 | pEC50 | 310 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 2009-2012 [PMID:19264481] |
ChEMBL | Agonist activity at LXRalpha ligand binding domain by FRET based SRC1 recruitment assay | B | 6.55 | pEC50 | 280 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 2009-2012 [PMID:19264481] |
ChEMBL | Agonist activity at human LXRalpha assessed as association of SRC1 to LXRalpha ligand binding domain by FRET based cell-free ligand sensing assay | B | 6.7 | pEC50 | 200 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 5617-5621 [PMID:19717304] |
GtoPdb | - | - | 6.7 | pEC50 | - | - | - | J Med Chem (2002) 45: 1963-6 [PMID:11985463] |
ChEMBL | Effective concentration in LXR alpha-Gal4 receptor gene assay | B | 6.72 | pEC50 | 190 | nM | EC50 | J Med Chem (2002) 45: 1963-1966 [PMID:11985463] |
ChEMBL | Agonist activity at LXRalpha by FRET assay | F | 6.76 | pEC50 | 175 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 1097-1100 [PMID:19167885] |
ChEMBL | Ligand-dependent recruitment of steroid receptor co-activator 1 (SRC1) to Liver X receptor-alpha | B | 6.9 | pEC50 | 125 | nM | EC50 | J Med Chem (2002) 45: 1963-1966 [PMID:11985463] |
ChEMBL | Agonist activity at GAL-linked human LXRalpha expressed in THP1 cells assessed as stimulation of coactivator recruitment by FRET assay | F | 7.01 | pEC50 | 97 | nM | EC50 | J Med Chem (2007) 50: 4255-4259 [PMID:17665897] |
ChEMBL | Effective concentration for Steroid receptor coactivator-1 (SRC1) recruitment to human LXRalpha (Liver X receptor) | B | 7.1 | pEC50 | 80 | nM | EC50 | J Med Chem (2005) 48: 5419-5422 [PMID:16107141] |
ChEMBL | Activity at human LXRalpha by Gal4 transactivation assay | B | 7.18 | pEC50 | 66 | nM | EC50 | J Med Chem (2007) 50: 4255-4259 [PMID:17665897] |
ChEMBL | Binding affinity to human LXRalpha | B | 7.66 | pEC50 | 22 | nM | EC50 | J Med Chem (2016) 59: 3264-3271 [PMID:26990539] |
Liver X receptor-β/LXR-beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4093] [GtoPdb: 601] [UniProtKB: P55055] | ||||||||
ChEMBL | Binding affinity to recombinant human LXRbeta-LBD expressed in Escherichia coli BL21 (DE3) assessed as inhibitory constant incubated for 30 mins by fluorescence polarization binding assay | B | 8.66 | pKi | 2.2 | nM | Ki | Eur J Med Chem (2019) 178: 458-467 [PMID:31202993] |
ChEMBL | Displacement of hyodeoxycholicacid-based fluorescent tracer from recombinant human LXRbeta LBD (215 to 461 residues) expressed in Escherichia coli BL21 (DE3) preincubated for 10 mins under shaking condition and measured after 30 mins by fluorescence polarization assay | B | 8.66 | pKi | 2.2 | nM | Ki | Eur J Med Chem (2020) 194: 112240-112240 [PMID:32248003] |
ChEMBL | Antagonist activity at LXRbeta ligand binding domain assessed as inhibition of T1317-induced transcriptional activity in african green monkey CV1 cells co-transfected with Gal4-SRC1 by luciferase reporter assay | B | 7.4 | pIC50 | 39.81 | nM | IC50 | J Med Chem (2010) 53: 3412-3416 [PMID:20345102] |
ChEMBL | Displacement of [N-methyl-3H]GW0438 from human biotinylated LXRbeta ligand binding domain | B | 7.52 | pIC50 | 30 | nM | IC50 | J Med Chem (2008) 51: 5758-5765 [PMID:18800767] |
ChEMBL | Displacement of [3H]T-0901317 from human LXR beta receptor | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2006) 49: 6151-6154 [PMID:17034119] |
ChEMBL | Displacement of [3H]TO901317 from human recombinant LXRbeta expressed in Escherichia coli by flashplate method | B | 7.92 | pIC50 | 12 | nM | IC50 | J Med Chem (2008) 51: 7161-7168 [PMID:18973288] |
ChEMBL | Displacement of [N-methyl-3H]T1317 from human biotinylated LXRbeta LBD after 3 hrs by LEAD seeker binding assay | B | 8.1 | pIC50 | 7.94 | nM | IC50 | J Med Chem (2010) 53: 3412-3416 [PMID:20345102] |
ChEMBL | Agonist activity at LXRbeta ligand binding domain-mediated transcriptional activity in african green monkey CV1 cells co-transfected with Gal4-SRC1 by luciferase reporter assay | B | 6.3 | pEC50 | 501.19 | nM | EC50 | J Med Chem (2010) 53: 3412-3416 [PMID:20345102] |
ChEMBL | Agonist activity at Gal4-tagged LXRbeta (unknown origin) expressed in CHOK1 cells after 24 hrs by luciferase reporter gene assay | B | 6.38 | pEC50 | 420 | nM | EC50 | Bioorg Med Chem Lett (2015) 25: 1274-1278 [PMID:25677664] |
ChEMBL | Agonist activity at human LXR beta receptor expressed in CHO cells by reporter assay | F | 6.39 | pEC50 | 410 | nM | EC50 | J Med Chem (2006) 49: 6151-6154 [PMID:17034119] |
ChEMBL | Agonist activity at LXRbeta (unknown origin) | B | 6.4 | pEC50 | 400 | nM | EC50 | Bioorg Med Chem Lett (2015) 25: 2668-2674 [PMID:25998501] |
ChEMBL | Agonist activity at human LXRbeta by Gal4 assay | B | 6.41 | pEC50 | 390 | nM | EC50 | J Med Chem (2016) 59: 3264-3271 [PMID:26990539] |
ChEMBL | Agonist activity at human recombinant LXRbeta ligand binding domain in human HuH7 cells co-transfected with fused Gal4-DBD by transactivation assay | B | 6.51 | pEC50 | 310 | nM | EC50 | J Med Chem (2008) 51: 7161-7168 [PMID:18973288] |
ChEMBL | Agonist activity at recombinant human LXRbeta-LBD expressed in Escherichia coli BL21 (DE3) assessed as peptide D22 recruitment fluorescence polarization binding assay | B | 6.54 | pEC50 | 289 | nM | EC50 | Eur J Med Chem (2019) 178: 458-467 [PMID:31202993] |
ChEMBL | Agonist activity at human LXRbeta expressed in human SH-SY5Y cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assay | F | 6.89 | pEC50 | 130 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 2009-2012 [PMID:19264481] |
ChEMBL | Agonist activity at LXRbeta ligand binding domain by FRET based SRC1 recruitment assay | B | 7.11 | pEC50 | 78 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 2009-2012 [PMID:19264481] |
ChEMBL | Agonist activity at human LXRbeta assessed as association of SRC1 to LXRbeta ligand binding domain by FRET based cell-free ligand sensing assay | B | 7.4 | pEC50 | 40 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 5617-5621 [PMID:19717304] |
ChEMBL | Agonist activity at LXRbeta LBD by HTRF cofactor peptide recruitment assay | F | 7.46 | pEC50 | 35 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 3473-3479 [PMID:17416521] |
ChEMBL | Agonist activity at human LXRbeta receptor after 1 hr by HTRF cofactor recruitment assay | F | 7.46 | pEC50 | 35 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4442-4446 [PMID:17587573] |
GtoPdb | - | - | 7.52 | pEC50 | - | - | - | J Med Chem (2002) 45: 1963-6 [PMID:11985463] |
ChEMBL | Agonist activity at GAL-linked human LXRbeta expressed in THP1 cells assessed as stimulation of co-activator recruitment by FRET assay | F | 7.57 | pEC50 | 27 | nM | EC50 | J Med Chem (2007) 50: 4255-4259 [PMID:17665897] |
ChEMBL | Agonist activity at LXRbeta by FRET assay | F | 7.6 | pEC50 | 25 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 1097-1100 [PMID:19167885] |
ChEMBL | Effective concentration for Steroid receptor coactivator-1 (SRC1) recruitment to human LXRbeta (Liver X receptor) | B | 7.7 | pEC50 | 20 | nM | EC50 | J Med Chem (2005) 48: 5419-5422 [PMID:16107141] |
ChEMBL | Agonist activity at human LXRbeta receptor transfected in COS7 cells after 16 hrs by reporter transactivation assay | F | 7.82 | pEC50 | 15 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4442-4446 [PMID:17587573] |
ChEMBL | Activation of LXRbeta co-transfected in COS7 cells with RXRalpha by reporter transactivation assay | F | 7.82 | pEC50 | 15 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 3473-3479 [PMID:17416521] |
ChEMBL | Binding to human LXRbeta | B | 8.3 | pEC50 | 5 | nM | EC50 | J Med Chem (2016) 59: 3264-3271 [PMID:26990539] |
ChEMBL | Activity at human LXRbeta by Gal4 transactivation assay | B | 8.4 | pEC50 | 4 | nM | EC50 | J Med Chem (2007) 50: 4255-4259 [PMID:17665897] |
Pregnane X receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3401] [GtoPdb: 606] [UniProtKB: O75469] | ||||||||
ChEMBL | Binding affinity to PXR by scintillation proximity binding assay | B | 5.7 | pKi | 2000 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 5617-5621 [PMID:19717304] |
Retinoid X receptor-α/Liver X receptor-β/Retinoic acid receptor RXR-alpha/oxysterols receptor LXR-beta in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3430878] [GtoPdb: 610, 601] [UniProtKB: P19793, P55055] | ||||||||
GtoPdb | - | - | 7.52 | pEC50 | - | - | - | J Med Chem (2002) 45: 1963-6 [PMID:11985463] |
ChEMBL | Agonist activity at human RXRalpha/LXRbeta expressed in HEK293 cells measured after 20 hrs by dual luciferase reporter gene assay | B | 9.64 | pEC50 | 0.23 | nM | EC50 | Eur J Med Chem (2020) 194: 112240-112240 [PMID:32248003] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]